Announcements Trials
Browse Landscape

Status

No longer available 1Available 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 155Observational 26Expanded_access 2

Sponsor

Cancer Type

CNS 3Breast 2Sarcoma 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 18Triple Negative Breast Neoplasms 6Pancreatic Neoplasms 5Prostatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Ovarian Neoplasms 3HER2-positive Breast Cancer 3Sarcoma 2Neoplasms 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Brain Neoplasms 2Triple Negative Local Advanced Breast Cancer 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Osteosarcoma 1Neurofibrosarcoma 1Neoplasms, Unknown Primary 1Neoplasms by Site 1Neoplasm Metastasis 1Metastatic gpNMB Expressing Triple Negative Breast Cancer 1Melanoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Head and Neck Neoplasms 1Glioblastoma 1Colonic Neoplasms 1Chordoma 1Chondrosarcoma 1Cholangiocarcinoma 1

Interventions

tucatinib 1Proton Pump Inhibitors 1Hydrocortisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Expanded_access × Brain Neoplasms × Breast × Clear all
NCT05974410 2025-10-02

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

AVM Biotechnology Inc

Available
BreastCNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Squamous Cell, Glioblastoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms

NCT03424473 2020-02-25

Expanded Access Use of Tucatinib for HER2+ Metastatic Breast Cancer

Seagen Inc.

No longer available
BreastCNS

Brain Neoplasms, Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon âš¡